Dual active 1, 4-dihydropyridine derivatives: Design, green synthesis and in vitro anti-cancer and anti-oxidant studies
- PMID: 33113411
- DOI: 10.1016/j.bioorg.2020.104379
Dual active 1, 4-dihydropyridine derivatives: Design, green synthesis and in vitro anti-cancer and anti-oxidant studies
Abstract
The present work describes the design of 1,4-dihydropyridines (1,4-DHPs) with diverse variations in structural and functional groups. The physico-chemical properties and drug-like molecule nature evaluations were carried out using SWISSADME. A simple, economical, eco-friendly, water-mediated and Para-Toluene sulfonic acid catalysed multicomponent and one-pot synthetic method from nitroketene N, S- acetals (NMSM) and corresponding aldehydes has been developed. All compounds (6a-u and 13a-h) were subjected to in vitro assays against two important human cancer cell lines Viz. are Laryngeal carcinoma (Hep2) and Lung adenocarcinoma (A549) cells. The reduction level of DPPH (%) used to evaluate the anti-oxidant properties. The 1,4-DHP derivatives, 6o, 6u and 6l displayed the potent anti-cancer activity with IC50 value of 10 µM, 14 µM and 10 µM against the Hep2 and 8 µM, 9 µM and 50 µM against the A549 cells. Similarly, the anti-oxidant properties of 6o, 6l and 6u at a standard concentration of 50 µg, are found to be 70.12%, 63.90% and 59.57% respectively favours the 1,4-DHP derivatives dual activity potentials. The compounds, 6o and 6l found to be equivalent with standard drug, Doxorubicin.
Keywords: 1,4-Dihydropyridine; Anti-cancer; Anti-oxidant; Green Chemistry; Nitroketene N; S-Acetals.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.Comb Chem High Throughput Screen. 2017;20(8):703-712. doi: 10.2174/1386207320666170724110015. Comb Chem High Throughput Screen. 2017. PMID: 28738766
-
Synthesis and antioxidant activity of new lipophilic dihydropyridines.Bioorg Chem. 2019 Mar;84:1-16. doi: 10.1016/j.bioorg.2018.11.009. Epub 2018 Nov 13. Bioorg Chem. 2019. PMID: 30471487
-
Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies.Bioorg Chem. 2021 Mar;108:104665. doi: 10.1016/j.bioorg.2021.104665. Epub 2021 Jan 27. Bioorg Chem. 2021. PMID: 33571809
-
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.Drug Des Devel Ther. 2021 Oct 13;15:4289-4338. doi: 10.2147/DDDT.S329547. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34675489 Free PMC article. Review.
-
Recent developments in the nanomaterial-catalyzed green synthesis of structurally diverse 1,4-dihydropyridines.RSC Adv. 2021 Jan 5;11(3):1376-1393. doi: 10.1039/d0ra07807g. eCollection 2021 Jan 4. RSC Adv. 2021. PMID: 35424131 Free PMC article. Review.
Cited by
-
Iodine catalyzed synthesis of imidazo[1,2-a]pyrazine and imidazo[1,2-a]pyridine derivatives and their anticancer activity.RSC Adv. 2023 Dec 13;13(51):36439-36454. doi: 10.1039/d3ra07842f. eCollection 2023 Dec 8. RSC Adv. 2023. PMID: 38093732 Free PMC article.
-
Synthesis of novel rapanone derivatives via organocatalytic reductive C-alkylation: biological evaluation of antioxidant properties, in vivo zebrafish embryo toxicity, and docking studies.RSC Med Chem. 2023 Dec 4;15(2):623-635. doi: 10.1039/d3md00564j. eCollection 2024 Feb 21. RSC Med Chem. 2023. PMID: 38389875 Free PMC article.
-
Substituted Dihydropyridine Synthesis by Dearomatization of Pyridines.Angew Chem Int Ed Engl. 2021 Jun 14;60(25):13793-13797. doi: 10.1002/anie.202104115. Epub 2021 May 10. Angew Chem Int Ed Engl. 2021. PMID: 33830616 Free PMC article.
-
Grignard Reagent Addition to Pyridinium Salts: A Catalytic Approach to Chiral 1,4-Dihydropyridines.ACS Catal. 2024 Aug 15;14(17):13030-13039. doi: 10.1021/acscatal.4c03520. eCollection 2024 Sep 6. ACS Catal. 2024. PMID: 39263543 Free PMC article.
-
Synthesis of efficient cobalt-metal organic framework as reusable nanocatalyst in the synthesis of new 1,4-dihydropyridine derivatives with antioxidant activity.Front Chem. 2022 Sep 8;10:932902. doi: 10.3389/fchem.2022.932902. eCollection 2022. Front Chem. 2022. Retraction in: Front Chem. 2023 Sep 04;11:1285183. doi: 10.3389/fchem.2023.1285183. PMID: 36157044 Free PMC article. Retracted.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous